David L. Kukis

2.9k total citations
57 papers, 2.4k citations indexed

About

David L. Kukis is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, David L. Kukis has authored 57 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Pathology and Forensic Medicine and 14 papers in Oncology. Recurrent topics in David L. Kukis's work include Radiopharmaceutical Chemistry and Applications (45 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and Lymphoma Diagnosis and Treatment (14 papers). David L. Kukis is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (45 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and Lymphoma Diagnosis and Treatment (14 papers). David L. Kukis collaborates with scholars based in United States, Switzerland and Norway. David L. Kukis's co-authors include Sally J. DeNardo, Gerald L. DeNardo, Claude F. Meares, Robert T. OʼDonnell, Laird Miers, Sui Shen, Linda A. Kroger, Kathleen R. Lamborn, Simon R. Cherry and Gary R. Mirick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

David L. Kukis

57 papers receiving 2.3k citations

Peers

Countries citing papers authored by David L. Kukis

Since Specialization

Citations

This map shows the geographic impact of David L. Kukis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Kukis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Kukis more than expected).

Fields of papers citing papers by David L. Kukis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Kukis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Kukis. The network helps show where David L. Kukis may publish in the future.

Co-authorship network of co-authors of David L. Kukis

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Kukis. A scholar is included among the top collaborators of David L. Kukis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Kukis. David L. Kukis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET) 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Takuya Toyonaga, Eric Berg, (unknown), Krista Fowles, Nabeel Nabulsi, Jim Ropchan, Songye Li, Yunpeng Ye, (unknown), David L. Kukis, Yiyun Huang, Helene Benveniste, Alice F. Tarantal, Stephanie M. Groman, Richard E. Carson	7
2	Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications 2017 ·PLoS ONE ·Kevin T. Campbell, (unknown), David L. Kukis, Eduardo A. Silva	42
3	Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication 2016 ·Journal of Neuroinflammation ·Brenna M. Flannery, Donald A. Bruun, Douglas J. Rowland, Christopher N. Banks, (unknown), David L. Kukis, Yonggang Li, Byron D. Ford, Daniel J. Tancredi, Jill L. Silverman, Simon R. Cherry, Pamela J. Lein	74
4	Initial investigation of three selective and potent small molecule oxytocin receptor PET ligands in New World monkeys 2016 ·Bioorganic & Medicinal Chemistry Letters ·Aaron L. Smith, Sara M. Freeman, Todd E. Barnhart, David H. Abbott, (unknown), David L. Kukis, Karen L. Bales, Mark M. Goodman, Larry J. Young	21
5	Radiolabeling Human Peripheral Blood Stem Cells for Positron Emission Tomography (PET) Imaging in Young Rhesus Monkeys 2013 ·PLoS ONE ·Alice F. Tarantal, C. Chang I. Lee, David L. Kukis, Simon R. Cherry	15
6	Pharmacokinetics and Biodistribution of a Human Monoclonal Antibody to Oxidized LDL in Cynomolgus Monkey Using PET Imaging 2012 ·PLoS ONE ·Amrita V. Kamath, Simon P. Williams, Sherry Bullens, Kyra J. Cowan, (unknown), Simon R. Cherry, S. V. Rendig, David L. Kukis, Chris D. Griesemer, Lisa A. Damico‐Beyer, Stuart Bunting	3
7	Imaging and Pharmacokinetics of 64Cu-DOTA-HB22.7 Administered by Intravenous, Intraperitoneal, or Subcutaneous Injection to Mice Bearing Non-Hodgkin’s Lymphoma Xenografts 2008 ·Molecular Imaging and Biology ·(unknown), Robert T. OʼDonnell, David L. Kukis, Craig K. Abbey, (unknown), Julie L. Sutcliffe, Joseph M. Tuscano	11
8	Cleavable Linkers to Enhance Selectivity of Antibody-Targeted Therapy of Cancer 2001 ·Cancer Biotherapy and Radiopharmaceuticals ·David L. Kukis, Ilse Novak‐Hofer, Sally J. DeNardo	15
9	Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and ⁹⁰yttrium‐DOTA‐peptide‐ChL6 2001 ·The Prostate ·Robert T. OʼDonnell, Sally J. DeNardo, Laird Miers, Kathleen R. Lamborn, David L. Kukis, Gerald L. DeNardo, Frederick J. Meyers	47
10	Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer. 2001 ·PubMed ·Robert T. OʼDonnell, Sally J. DeNardo, A. Yuan, Sui Shen, Carol M. Richman, Primo N. Lara, I J Griffith, D S Goldstein, David L. Kukis, (unknown), Gary R. Mirick, Gerald L. DeNardo, Frederick J. Meyers	42
11	Are Radiometal-Labeled Antibodies Better Than Iodine-131–Labeled Antibodies: Comparative Pharmacokinetics and Dosimetry of Copper-67–, Iodine-131–, and Yttrium-90–Labeled Lym-1 Antibody in Patients with Non-Hodgkin's Lymphoma 2000 ·Clinical Lymphoma ·Gerald L. DeNardo, Sally J. DeNardo, Robert T. OʼDonnell, Linda A. Kroger, David L. Kukis, Claude F. Meares, D. Goldstein, Sui Shen	31
12	¹³¹ I-Lym-1 in Mice Implanted with Human Burkitt's Lymphoma (Raji) Tumors: Loss of Tumor Specificity due to Radiolysis 2000 ·Cancer Biotherapy and Radiopharmaceuticals ·Gerald L. DeNardo, Sally J. DeNardo, Barry W. Wessels, David L. Kukis, (unknown), Aina Yuan	10
13	Efficacy and toxicity of radioimmunotherapy with90Y-DOTA-peptide-ChL6 for PC3-tumored mice 2000 ·The Prostate ·Robert T. OʼDonnell, Sally J. DeNardo, Gerald L. DeNardo, Laird Miers, Kathleen R. Lamborn, David L. Kukis, Frederick J. Meyers	5
14	Stability of Monoclonal Antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 Immunoconjugate with Ultra Freezer Storage 1999 ·Cancer Biotherapy and Radiopharmaceuticals ·David L. Kukis, Sally J. DeNardo, (unknown), Sui Shen, Robert T. OʼDonnell, Gerald L. DeNardo	4
15	Radioimmunotherapy of Acquired Immunodeficiency Syndrome (AIDS) Associated Lymphoma 1999 ·Cancer Biotherapy and Radiopharmaceuticals ·Robert T. OʼDonnell, Bryan R. Leigh, Scott Christensen, D S Goldstein, David L. Kukis, Sui Shen, Aina Yuan, Diane A. DeNardo, Linda A. Kroger, Gerald L. DeNardo	3
16	Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study. 1998 ·PubMed ·Gerald L. DeNardo, Sally J. DeNardo, David L. Kukis, Robert T. OʼDonnell, Sui Shen, D. Goldstein, Linda A. Kroger, Qansy Salako, Diane A. DeNardo, Gary R. Mirick, L.F. Mausner, S.C. Srivastava, Claude F. Meares	53
17	Enhancement of67Cu-2IT-BAT-LYM-1 therapy in mice with human burkitt's lymphoma (Raji) using interleukin-2 1997 ·Cancer ·Gerald L. DeNardo, David L. Kukis, Sally J. DeNardo, Sui Shen, L.F. Mausner, Robert T. OʼDonnell, Kathleen R. Lamborn, Frederick J. Meyers, S.C. Srivastava, Laird Miers	8
18	Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy. 1995 ·PubMed ·(unknown), Claude F. Meares, Qansy Salako, David L. Kukis, (unknown), Laird Miers, Sally J. DeNardo	10
19	A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates 1994 ·Cancer ·David L. Kukis, (unknown), Douglas P. Greiner, Sally J. DeNardo, Gerald L. DeNardo, Qansy Salako, Claude F. Meares	55
20	Influence of a peptide linker on biodistribution and metabolism of antibody-conjugated benzyl-EDTA. Comparison of enzymic digestion in vitro and in vivo 1992 ·Bioconjugate Chemistry ·Martin Studer, Linda A. Kroger, Sally J. DeNardo, David L. Kukis, Claude F. Meares	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact